How does tobacco smoke contribute to cervical carcinogenesis?

Journal of Virology

Volumn 82, Issue 12, 2008, Pages 6084-6085

  Castle, Philip E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; DNA; ONCOPROTEIN; PROTEIN E6; PROTEIN E7; TOBACCO SMOKE;

CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; DNA DAMAGE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LETTER; MOLECULAR INTERACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; UTERINE CERVIX CARCINOMA; VIRUS GENOME; VIRUS LOAD; VIRUS MORPHOGENESIS; WART VIRUS;

CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; TOBACCO SMOKE POLLUTION; UTERINE CERVICAL NEOPLASMS;

NICOTIANA TABACUM;

EID: 44949231395     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00103-08     Document Type: Letter

References (10)

1. Alam, S., M. J. Conway, H. S. Chen, and C. Meyers. 2008. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J. Virol. 82:1053-1058.
2. Castellsague, X., and N. Munoz. 2003. Chapter 3: cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J. Natl. Cancer Inst. Monogr. 2003:20-28.
3. Castle, P. E., S. Wacholder, A. T. Lorincz, D. R. Scott, M. E. Sherman, A. G. Glass, B. B. Rush, J. E. Schussler, and M. Schiffman. 2002. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J. Natl. Cancer Inst. 94:1406-1414.
4. Gravitt, P. E., R. D. Burk, A. Lorincz, R. Herrero, A. Hildesheim, M. E. Sherman, M. C. Bratti, A. C. Rodriguez, K. J. Helzlsouer, and M. Schiffman. 2003. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomarkers Prev. 12:477-484.
5. Gravitt, P. E., M. B. Kovacic, R. Herrero, M. Schiffman, C. Bratti, A. Hildesheim, J. Morales, M. Alfaro, M. E. Sherman, S. Wacholder, A. C. Rodriguez, and R. D. Burk. 2007. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease. Int. J. Cancer. 121:2787-2793.
6. McIntyre-Seltman, K., P. E. Castle, R. Guido, M. Schiffman, and C. M. Wheeler. 2005. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol. Biomarkers Prev. 14:1165-1170.
7. Pratt, M. M., P. Sirajuddin, M. C. Poirier, M. Schiffman, A. G. Glass, D. R. Scott, B. B. Rush, O. A. Olivero, and P. E. Castle. 2007. Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study. Mutat. Res. 624:114-123.
8. Schiffman, M., and M. E. Adrianza. 2000. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 44:726- 742.
9. Song, S., A. Liem, J. A. Miller, and P. F. Lambert. 2000. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267:141-150.
10. Spardy, N., A. Duensing, D. Charles, N. Haines, T. Nakahara, P. F. Lambert, and S. Duensing. 2007. The human papillomavirus type 16 E7 oncoprotein activates the Fanconi anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. J. Virol. 81:13265-13270.